Olanzapine - Nausea and vomiting (chemotherapy induced)
You are here : Home > Formulary Search > Olanzapine - Nausea and vomiting (chemotherapy induced)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Oro-dispersible tablets
- Tablets
Formulary Status :
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important
Off-label use.
Status 2
Non Formulary
Formulations :
- Oral lyophilisates
Formulary Status :
Associated Icons :
NFD1
SPC
Restrictions / Comments :
Important
Oral lyophilisates are considerably more expensive than orodispersible tablets.
Orodispersible tablets should be used in preference to oral lyophilisates
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Olanzapine
Indication :
Nausea and vomiting (chemotherapy induced)
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Committee Recommendations (1)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Other Indications
Below are listed other indications that Olanzapine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Nausea and vomiting (chemotherapy induced).